The Impact of Insufficient Oversight

Pharmaceutical Technology Europe asked Vincent Colicchio, vice president, supply chain and external manufacturing at Dr. Reddy's Laboratories, about how a lack of proper supplier oversight can impact the pharmaceutical industry and the drug supply chain. Colicchio (Dr. Reddy's): There are...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical technology Europe 2021-09, Vol.33 (9), p.40-40
Main Author: Haigney, Susan
Format: Article
Language:English
Subjects:
Contract manufacturing
FDA approval
Logistics
Manufacturers
Manufacturing
Pharmaceutical industry
Suppliers
Supply chains
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pharmaceutical Technology Europe asked Vincent Colicchio, vice president, supply chain and external manufacturing at Dr. Reddy's Laboratories, about how a lack of proper supplier oversight can impact the pharmaceutical industry and the drug supply chain. Colicchio (Dr. Reddy's): There are several important materials in the pharmaceutical supply chain such as APIs; key starting materials for API production; excipients; purified water; and packaging materials including bottles, closures, vials, and printed components. While there are a wide variety of potential issues in this category, it is particularly important that the contract manufacturers properly operate and sanitize the purified water system that is used for production operations and cleaning purposes.
ISSN:1753-7967